Lujuan Wang

1.5k total citations · 1 hit paper
37 papers, 1.1k citations indexed

About

Lujuan Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lujuan Wang has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Lujuan Wang's work include RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (6 papers) and Axon Guidance and Neuronal Signaling (5 papers). Lujuan Wang is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (6 papers) and Axon Guidance and Neuronal Signaling (5 papers). Lujuan Wang collaborates with scholars based in China, Saudi Arabia and Ethiopia. Lujuan Wang's co-authors include Juanjuan Xiang, Guiyuan Li, Buqing Sai, Jingqun Tang, Leliang Zheng, Xina Zhang, Fan Wang, Yuhui Wang, Peng Qiu and Xiang Zheng and has published in prestigious journals such as Journal of Virology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Lujuan Wang

34 papers receiving 1.0k citations

Hit Papers

Hypoxic BMSC-derived exosomal miRNAs promote metastasis o... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lujuan Wang China 16 733 458 196 122 103 37 1.1k
Yin Zhao China 21 645 0.9× 381 0.8× 211 1.1× 148 1.2× 98 1.0× 69 1.2k
Yunlong He China 19 657 0.9× 222 0.5× 244 1.2× 69 0.6× 95 0.9× 50 1.1k
Dongfang Wang China 14 783 1.1× 354 0.8× 137 0.7× 133 1.1× 164 1.6× 21 1.1k
Jiaqi Huang China 12 446 0.6× 287 0.6× 64 0.3× 127 1.0× 57 0.6× 22 817
Man‐Hung Eric Tang Denmark 10 755 1.0× 505 1.1× 285 1.5× 83 0.7× 188 1.8× 23 1.3k
Yun Yan China 11 874 1.2× 466 1.0× 167 0.9× 140 1.1× 129 1.3× 15 1.2k
Ming Zheng China 19 735 1.0× 601 1.3× 165 0.8× 206 1.7× 84 0.8× 67 1.2k
Shumin Zhou China 20 913 1.2× 353 0.8× 127 0.6× 157 1.3× 57 0.6× 66 1.3k
Barbara T. Grünwald Germany 13 348 0.5× 262 0.6× 429 2.2× 270 2.2× 106 1.0× 27 1.0k
Lance Liotta United States 10 449 0.6× 179 0.4× 254 1.3× 85 0.7× 66 0.6× 14 818

Countries citing papers authored by Lujuan Wang

Since Specialization
Citations

This map shows the geographic impact of Lujuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lujuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lujuan Wang more than expected).

Fields of papers citing papers by Lujuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lujuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lujuan Wang. The network helps show where Lujuan Wang may publish in the future.

Co-authorship network of co-authors of Lujuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lujuan Wang. A scholar is included among the top collaborators of Lujuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lujuan Wang. Lujuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Peng, Lujuan Wang, Ying Long, et al.. (2025). SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression. Journal of Advanced Research. 79. 505–520. 3 indexed citations
4.
Wang, Lujuan, et al.. (2024). Molecular Mechanism During Mycelium Subculture Degeneration of Volvariella volvacea. Journal of Fungi. 11(1). 7–7. 2 indexed citations
5.
Li, Yanling, et al.. (2024). LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration. Aging. 16(2). 1484–1495. 5 indexed citations
6.
Liu, Xianling, Juanjuan Xiang, Jiaqi Xu, et al.. (2023). Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-β pathway. Translational Lung Cancer Research. 12(12). 2520–2537. 12 indexed citations
7.
Zhang, Liyang, Lujuan Wang, Bo Chen, et al.. (2023). EphB1 promotes the differentiation and maturation of dendritic cells in non-small cell lung cancer. Cancer Letters. 582. 216567–216567. 2 indexed citations
8.
Qiu, Peng, Lujuan Wang, Liang Zuo, et al.. (2023). HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Cancer Gene Therapy. 31(1). 9–17. 31 indexed citations
9.
Yi, Zhengjun, Liqian Yin, Lujuan Wang, et al.. (2022). Amentoflavone impairs the reconsolidated fear memories through inhibition of ERK pathway. Biochemical and Biophysical Research Communications. 622. 8–14. 1 indexed citations
10.
Wang, Lujuan, Peng Qiu, Na Yin, et al.. (2022). Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy. Cell Death and Disease. 13(11). 980–980. 13 indexed citations
11.
Wang, Lujuan, Peng Qiu, Na Yin, et al.. (2021). Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation. Molecular Therapy — Nucleic Acids. 26. 269–279. 18 indexed citations
12.
Wang, Lujuan, Peng Qiu, Buqing Sai, et al.. (2020). Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration. Journal of Cancer. 11(14). 4123–4131. 17 indexed citations
13.
Zheng, Xiang, Peng Qiu, Lujuan Wang, et al.. (2020). Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer. International Journal of Biological Sciences. 16(13). 2442–2453. 82 indexed citations
14.
Zheng, Leliang, Jiaqi Xu, Buqing Sai, et al.. (2020). Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development. Frontiers in Oncology. 10. 531131–531131. 14 indexed citations
15.
Zhang, Xina, Buqing Sai, Fan Wang, et al.. (2019). Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Molecular Cancer. 18(1). 40–40. 436 indexed citations breakdown →
16.
Sun, Yanli, Jiaqiu Li, Yanhua Sun, et al.. (2019). A Stable Pep2-proapoptotic Peptide Inducing Apoptosis of Acute Myeloid Leukemia Cells by Down-Regulating EZH2. Cellular and Molecular Bioengineering. 13(2). 165–177. 3 indexed citations
17.
Sai, Buqing, Yafei Dai, Songqing Fan, et al.. (2019). Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs. Cell Death and Disease. 10(12). 941–941. 55 indexed citations
18.
Qiu, Peng, Ling Chen, Jia Wang, et al.. (2018). EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer. Cell Death and Disease. 9(12). 1146–1146. 42 indexed citations
19.
Cao, Pengfei, Meili Zhang, Lujuan Wang, et al.. (2018). miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas. BMC Cancer. 18(1). 1293–1293. 16 indexed citations
20.
Cao, Pengfei, Meili Zhang, Wei Wang, et al.. (2017). Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. BMC Infectious Diseases. 17(1). 323–323. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026